Novartis India Ltd. benchmarking: Perfomance to industry peers

Financial

	Novartis	Bliss GVS Pharma	Beta Drugs
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	-5.28 %	n/a	n/a
Financials
5 yr Average ROE	8.0 %	6.83 %	21.73 %
5yr average Equity Multiplier	2.72	1.3	1.75
5yr Average Asset Turnover Ratio	0.18	0.62	1.04
5yr Avg Net Profit Margin	17.12 %	8.7 %	11.97 %
Price to Book	2.68	1.56	0.0
P/E	19.48	16.13	39.87
5yr Avg Cash Conversion Cycle	-23.33 Days	186.56 Days	15.7 Days
Inventory Days	44.27 Days	54.35 Days	43.83 Days
Days Receivable	38.18 Days	189.93 Days	87.61 Days
Days Payable	124.28 Days	75.78 Days	113.94 Days
5yr Average Interest Coverage Ratio	65.43	14.68	13.71
5yr Avg ROCE	5.91 %	13.27 %	27.85 %
5yr Avg Operating Profit Margin	15.15 %	17.03 %	21.58 %
5 yr average Debt to Equity	0.0	0.11	0.23
5yr CAGR Net Profit	37.01 %	4.24 %	31.07 %
5yr Average Return on Assets	3.13 %	5.31 %	12.53 %
Shareholdings
Promoter Holding	70.68 %	35.39 %	66.73 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.84 %	0.02 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Novartis	Bliss GVS Pharma	Beta Drugs
Product Wise Break-Up	Product Wise Break-Up Wholesale of pharmaceuticals and medical goods 100.0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Manufacturing of Oncology medicines 0	Product Wise Break-Up Anti-fungal 16.0 Manufacturing of Oncology medicines 0 0 Anti Malarials 43.0 Anti-bacterial 0 Antibiotics 5.0 Anti Inflammatory 7.0 Others 29.0	Product Wise Break-Up Anti-fungal, 0 Oncology 100.0 0 Antimalarial 0 Anti-bacterial 0 Anti-biotic 0 Anti Inflammatory 0
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0 Domestic 0	Location Wise Break-Up India 6.61 Rest of the World 93.39 Domestic 0	Location Wise Break-Up India 0 Rest of the World 0 India 71.03 Others 28.97